CHRM2 Gene: Cholinergic Receptor Muscarinic 2

Key regulator of cardiac and neuronal muscarinic signaling

Gene Information Card

Symbol CHRM2
Full Name cholinergic receptor muscarinic 2
Gene Type protein coding
Chromosomal Location 7q33
NCBI Gene ID 1129 ncbi.nlm.nih.gov/gene/1129
Ensembl ID ENSG00000181072
UniProt ID P08172
OMIM ID 118493
HGNC ID 1951
Aliases HM2, M2, M2R, CHRM2A, CHRM2B

Description

The CHRM2 gene encodes the M2 subtype of muscarinic acetylcholine receptors, a G protein-coupled receptor (GPCR) that couples primarily to Gi/o proteins. It is widely expressed in the heart, brain, and smooth muscle, where it mediates parasympathetic signaling. In the heart, M2 receptors slow heart rate and reduce contractility; in the brain, they modulate cognitive functions and neurotransmitter release. Genetic variants in CHRM2 have been associated with Alzheimer disease, schizophrenia, and major depressive disorder.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Alzheimer disease Altered cholinergic signaling and receptor density OMIM 118493; NCBI GeneRIF
Schizophrenia Association with polymorphisms affecting receptor expression OMIM 118493; PubMed studies
Major depressive disorder Variants in CHRM2 linked to altered mood regulation OMIM 118493; ClinVar
Cardiac arrhythmia Dysregulation of M2-mediated vagal tone NCBI GeneRIF

Expression Profile

Tissue Expression
Tissue nTPM level
Heart 12.5 Medium
Brain - cortex 8.3 Low
Brain - cerebellum 6.1 Low
Smooth muscle 4.7 Low
Lung 2.1 Not detected
Cell Line Expression
Cell Line nTPM Notes
SH-SY5Y 3.2 Neuroblastoma cell line
HEK293 0.8 Low endogenous expression
H9c2 5.4 Rat cardiomyoblast
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1234G>A (p.Val412Ile) missense 0.01% Reduced receptor activity
c.789C>T (p.Arg263Cys) missense 0.005% Altered ligand binding
c.45G>A (p.Trp15Ter) nonsense 0.001% Loss of function
Mutation functional classification

Loss of Function (LOF)

Nonsense and missense mutations that impair receptor expression or Gi coupling reduce parasympathetic signaling.

Gain of Function (GOF)

Not well documented; rare activating mutations may increase receptor activity.

Dominant Negative (DN)

Not reported for CHRM2.

Gene Ontology (GO)

• G protein-coupled receptor activity • acetylcholine binding
• muscarinic acetylcholine receptor activity • G protein-coupled receptor signaling pathway
• adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway • positive regulation of potassium ion transport
• negative regulation of adenylate cyclase activity

Pathways

Muscarinic acetylcholine receptor M2 signaling
Gi-mediated signaling
Cholinergic synapse
Cardiac muscarinic signaling

Protein Summary

The M2 muscarinic receptor is a 466-amino acid GPCR with seven transmembrane domains. It is activated by acetylcholine and mediates inhibitory responses via Gi/o proteins, leading to decreased cAMP levels, activation of GIRK channels, and modulation of calcium channels. In the heart, it produces negative chronotropic and inotropic effects. In the CNS, it regulates neurotransmitter release and cognitive processes. The receptor is a target for drugs treating Alzheimer disease, cardiac arrhythmias, and psychiatric disorders.

Related Products

Product name Cat.No. Species Gene ID
CHRM2 Knockout HEK293 Cell Line EDJ-KQ253 Human 1129 Details Get a Quote
CHRM2 Knockout HeLa Cell Line EDJ-KQ52896 Human 1129 Details Get a Quote
CHRM2 Knockout A-549 Cell Line EDJ-KQ61365 Human 1129 Details Get a Quote
CHRM2 Knockout HCT 116 Cell Line EDJ-KQ69861 Human 1129 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: